HHS Drug Pricing Plan: Mum On National Cost Effectiveness Program, Cautious On QALYs

 
• By Cathy Kelly
  
Administration Has Yet To Describe How To Define Drug Value • Source: Alamy

More from Market Access

More from Pink Sheet